PARD (Poniard Pharmaceuticals) Interest Expense: $-0.54 Mil (TTM As of Sep. 2011)


What is Poniard Pharmaceuticals Interest Expense?

Poniard Pharmaceuticals PARD Interest Expense is $-0.54 Mil as of Sep. 2011.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Poniard Pharmaceuticals's interest expense for the three months ended in Sep. 2011 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2011 was $-0.54 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Poniard Pharmaceuticals's Operating Income for the three months ended in Sep. 2011 was $ -3.75 Mil. Poniard Pharmaceuticals's Interest Expense for the three months ended in Sep. 2011 was $ -0.02 Mil. Poniard Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poniard Pharmaceuticals  (OTCPK:PARD) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poniard Pharmaceuticals's Interest Expense for the three months ended in Sep. 2011 was $-0.02 Mil. Its Operating Income for the three months ended in Sep. 2011 was $-3.75 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2011 was $1.64 Mil.

Poniard Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2011 is calculated as

Poniard Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Poniard Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Interest Expense Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1.90 -3.14 -2.21

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.52 -0.47 -0.02 -0.02 -0.02

Poniard Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.54 Mil mean?
Poniard Pharmaceuticals (PARD) has a Interest Expense of $-0.54 Mil as of Sep. 2011. Interest Expense is the amount a company pays on its long-term debt. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Interest Expense too high?
Poniard Pharmaceuticals' current Interest Expense is $-0.54 Mil.
How does Poniard Pharmaceuticals' Interest Expense compare to OBMP and NSPX?
Poniard Pharmaceuticals' Interest Expense of $-0.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Interest Expense is $-0.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Interest Expense of $-0.54 Mil. The current Interest Expense is $-0.54 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Interest Expense is $-0.54 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.